These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1511165)

  • 1. Treatment of chronic neutropenia of childhood responsive to cyclosporin A in vitro and in vivo.
    Janka-Schaub GE; Raghavachar A; Rister M; Belohradsky BM
    Int J Hematol; 1992 Apr; 55(2):157-63. PubMed ID: 1511165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia.
    Wright DG; LaRussa VF; Salvado AJ; Knight RD
    J Clin Invest; 1989 Apr; 83(4):1414-8. PubMed ID: 2649515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between availability of GM progenitors and endogenous CSA production in neutropenia].
    Ghizzi A; De Caro L
    Boll Soc Ital Biol Sper; 1993 Sep; 69(9):541-8. PubMed ID: 8155312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid progenitor cell growth characteristics and effect of G-CSF in a patient with congenital cyclic neutropenia.
    Tsunogake S; Nagashima S; Maekawa R; Takano N; Kajitani H; Saito K; Enokihara H; Furusawa S; Shishido H
    Int J Hematol; 1991 Jun; 54(3):251-6. PubMed ID: 1720982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient erythroblastopenia of childhood. Evidence for cell-mediated suppression of erythropoiesis.
    Tamary H; Kaplinsky C; Shvartzmayer S; Umiel T; Pecht M; Levin S; Zaizov R
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):386-91. PubMed ID: 8214360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a CD4+ T cell clone recognizing autologous hematopoietic progenitor cells from a patient with immune-mediated aplastic anemia.
    Nakao S; Takamatsu H; Yachie A; Itoh T; Yamaguchi M; Ueda M; Shiobara S; Matsuda T
    Exp Hematol; 1995 May; 23(5):433-8. PubMed ID: 7720814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
    Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
    Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
    Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
    Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
    Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective CSA-dependent granulopoiesis in patients with chronic drug-induced neutropenia.
    Eliopoulos G; Meletis J; Fessas P; Anagnou NP
    Haematologia (Budap); 1990; 23(2):101-9. PubMed ID: 2272534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of granulopoiesis in human cyclic neutropenia.
    Cukrová V; Klamová H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):647-52. PubMed ID: 1709897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.